Guilford Pharmaceuticals Inc. Invites You to Listen to a Replay of Its Third Quarter Conference Call on the Web

Baltimore (ots-PRNewswire) - In conjunction with Guilford Pharmaceuticals Inc. (Nasdaq: GLFD) Third Quarter earnings release, you are invited to listen to a replay of its conference call with Dr. Craig Smith, President and CEO of Guilford Pharmaceuticals. The replay will be available on the Internet today, October 29, 1999.

What: Guilford Pharmaceuticals Third Quarter Earnings Release

When: Today, Oct. 29

Where: http://www.videonewswire.com/GUILFORD/102599

How: Simply log on to the web at the address above and click investor relations, then third quarter conference call.

Contact: Stacey Jurchison, (in the USA) 410-631-5022, or Angela Rubin, (in the USA) 410-631-6449, both Corporate Communications of Guilford Pharmaceuticals

Third Quarter Conference Call Highlights:

-- Completion of private financing which raised net proceeds of approximately $42 million

-- Receipt of milestone payments totaling $4.5 million for approval to market GLIADEL(R) Wafer in France and Germany

-- Initiation of Phase I neuroimmunophilin clinical trial in Europe

-- Completion of preclinical testing of PACLIMER(TM) Injection

-- Engaged Gynecologic Oncology Group to conduct Phase I/II clinical trial for PACLIMER(TM) Injection

-- Updates on NAALADase and PARP inhibitor research programs

Guilford Pharmaceuticals Inc. is a biopharmaceutical company engaged in the development of polymer-based therapeutics for cancer, and novel products for the diagnosis and treatment of neurological diseases, including Parkinson's disease, Alzheimer's disease, stroke, severe head trauma, spinal cord injuries, multiple sclerosis, and peripheral neuropathies.

The call will be archived on the Web site http://www.guilfordpharm.com. To access the replay, click on What's New or Investor Relations. The call will also be archived at www.prnewswire.com.

(Minimum Requirements to listen to broadcast: The RealPlayer software, downloadable free from www.real.com/products/player/index.html, and at least a 14.4Kbps connection to the Internet. If you experience problems listening to the broadcast, send an email to webmaster@vdat.com.)

ots Original Text Service: Guilford Pharmaceuticals Inc.
Internet: http://www.newsaktuell.de

Contact: Stacey Jurchison, 410-631-5022, or Angela Rubin, 410-631-6449, both Corporate Communications of Guilford Pharmaceuticals

Company News On-Call: http://www.prnewswire.com/comp/112882.html or fax, 800-758-5804, ext. 112882

Web site: http://www.guilfordpharm.com

Audio: http://www.videonewswire.com/GUILFORD/102599

*** OTS-ORIGINALTEXT UNTER AUSSCHLIESSLICHER INHALTLICHER

VERANTWORTUNG DES AUSSENDERS ***

OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS | HER/06